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Abstract
Two different formulations of cyclodextrin nanosponges (CDNS), obtained by polycondensation of β-cyclodextrin with ethylene-
diaminetetraacetic acid dianhydride (EDTAn), were treated with aqueous solutions of ibuprofen sodium salt (IbuNa) affording
hydrogels that, after lyophilisation, gave two solid CDNS-drug formulations. 1H fast MAS NMR and 13C CP-MAS NMR spectra
showed that IbuNa was converted in situ into its acidic and dimeric form (IbuH) after freeze-drying. 13C CP-MAS NMR spectra
also indicated that the structure of the nanosponge did not undergo changes upon drug loading compared to the unloaded system.
However, the 13C NMR spectra collected under variable contact time cross-polarization (VCT-CP) conditions showed that the poly-
meric scaffold CDNS changed significantly its dynamic regime on passing from the empty CDNS to the drug-loaded CDNS, thus
showing that the drug encapsulation can be seen as the formation of a real supramolecular aggregate rather than a conglomerate of
two solid components. Finally, the structural features obtained from the different solid-state NMR approaches reported matched the
information from powder X-ray diffraction profiles.
Introduction
In the last ten years cyclodextrin nanosponges (CDNS) polymer
materials received great attention as promising new materials in
several fields of applications such as bio-catalysis, agriculture,
analytical chemistry [1,2] and in pharmaceutical research. Their
wide applicability is mostly due to their nanoporous structure,
along with their high chemical and thermal stabilities. Consid-
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ering the pharmaceutical applications, they received interest as
drug carriers, since these materials are able to accommodate
small drug molecules within their porous network made of CD
lipophilic cavities and more hydrophilic polymer channels orig-
inated during the cross-linking process with suitable cross-
linking agents (CL). The polymer is obtained by condensation
reaction of the OH groups of the glucopyranose units of cyclo-
dextrins (CD) with a poly-functional cross-linking agent [3].
CDNS have been characterized, in the solid state, by a reper-
toire of physical methods such as solid-state 13C CP-MAS
NMR, FTIR and Raman spectroscopy [4-6]. Moreover, in many
of their formulations, CDNS showed good swelling capability
when contacted with water solutions, giving rise to homoge-
neous hydrogels potentially useful as drug carriers [7]. In order
to obtain an effective control over the drug delivery procedure,
several efforts have been made to explore how the nanoporous
polymer structure influences the delivery property of entrapped
drugs [8]. In particular the transport properties of ibuprofen so-
dium salt (IbuNa) entrapped in CDNS polymer gels has been in-
vestigated by high resolution magic angle spinning (HR-MAS)
NMR technique [9] as a paradigmatic case of an active pharma-
ceutical ingredient (API) entrapped in a polymeric scaffold. The
results pointed out that the motion of a small drug molecule
drastically changes from subdiffusive to slightly superdiffusive
regimes depending on the cyclodextrin to CL molar ratio, and
hence on the CDNS polymeric structure. Ibuprofen is the API
of many nonsteroidal anti-inflammatory formulations widely
used in the treatment of fever, rheumatoid arthritis and other in-
flammatory diseases [10]. From the chemical viewpoint,
ibuprofen is the (RS)-2-(4-(2-methylpropyl)phenyl)propanoic
acid. Its sodium salt is water-soluble and absorbed in blood
plasma more quickly than the undissociated acid [11]. In the
following, we will refer to the undissociated acid as IbuH and to
the sodium salt as IbuNa. For both IbuH and IbuNa, the desired
pharmacological effects are due to the S-enantiomer. Neverthe-
less, the commercially available drug is the racemic mixture
(R,S)-ibuprofen. Moreover, solid-state NMR spectra revealed
that in all tablet samples, ibuprofen is present in acidic form
IbuH with different contents of bound water within tablets [12]
depending on the formulation.
In this work the racemic (R,S)-ibuprofen sodium salt (IbuNa)
was encapsulated in cyclodextrin nanosponges (CDNS) ob-
tained by cross-linking of β-cyclodextrin with ethylenediamine-
tetraacetic acid dianhydride (EDTAn) in two different prepara-
tions: CDNS(1:4) and CDNS(1:8), where the 1:n notation indi-
cates the CD to EDTAn molar ratio used for the synthesis. The
solid state products were prepared via freeze-drying of the
hydrogels obtained by swelling the nanosponge with aqueous
solutions of IbuNa. The main purpose of the present work is to
investigate the structural changes of the host CDNS material as
well as the drug chemical and structural modifications in the
polymer network in the solid state. The methodological ap-
proach here presented relies upon two different solid state NMR
methodologies and it is finally supported by powder X-ray
diffraction (PXRD) data. In particular, here we present the use
of variable contact time (VCT) cross-polarization 13C NMR as
a novel and powerful source of information on the drug loaded
polymers, complementary to the chemical shift data achievable
with the commonly employed 13C CP-MAS NMR spectra. In a
typical VCT experimental session, an array of CP-MAS spectra
are collected by modulating the contact time needed for cross
polarization. The experimental data can be fitted by using suit-
able theoretical models. When feasible, the fitting procedure
affords important relaxation parameters such as the proton spin-
lattice relaxation times T1ρ(H) and the 1H–13C cross-polariza-
tion time constant TCH. In general, the outcome of VCT data
processing is a “dynamic fingerprint” that can be used for the
characterization of the polymer-drug system.
In general, the CP-VCT methodology can be exploited to
provide a dynamic characterization of polymeric systems which
are expected to be structurally similar, as recently demonstrated
for molecular imprinted epichlorohydrin–cyclodextrin poly-
mers [13]. In the present work, CDNS(1:4) and CDNS(1:8),
along with the corresponding ibuprofen loaded systems, are
used as a paradigmatic case. The CDNS do not show signifi-
cant chemical shift variations on passing from the unloaded
polymers to the drug-loaded systems, thus making their charac-
terization difficult. The dynamic fingerprint provided by the
VCT data allows overcoming this problem. In a broader sense,
CP-VCT techniques can be considered a convenient approach
for systems in which the common NMR parameters, like chemi-
cal shift and line-width, may fail to provide an acceptable
characterization due to high structural similarity at molecular
level.
Finally yet importantly, in the present work we also report on
solid state 1H NMR spectra of the examined compounds
acquired under fast magic angle spinning (Fast MAS) condi-
tions. As detailed in the Discussion, this technique is quite
rarely used. The results of the 1H Fast MAS NMR experiments
provided further structural details of the state of the drug mole-
cule loaded in the CDNS materials.
Theoretical Aspects
The CP-MAS experiment and CP dynamics
Cross-polarization (CP) is a SSNMR technique originally de-
veloped for enhancing the signal intensities of low-abundance
spins, generally referred to as S spins (typically 13C, 15N, 29Si
etc.) by polarization transfer from high-abundance spins, in turn
labelled as I spins (usually protons). The transfer of magnetiza-
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 1: Schematic thermodynamic description of the CP process and time constants. The I-S model (left), the I–I*–S model (right). Adapted with
permission from [14]. Copyright 2002 American Chemical Society.
tion occurs via heteronuclear dipolar interaction between the
two spin species (I–S) when the Hartmann–Hahn condition is
met. In the present work only 1H,13C magnetization transfer
will be considered, thus the Hartmann–Hahn condition can be
expressed as: γ(1H)B1(1H) = γ(13C)B1(13C), where γ are the
gyromagnetic ratios of the nuclei and B1 is the so-called spin-
lock field generated by the spectrometer acquisition hardware.
The efficiency of the CP process strongly depends on the struc-
tural and dynamic properties of the system, in particular molec-
ular conformational changes, rotational dynamics and internu-
clear distances in the solid state. The CP dynamic regime can be
explored by acquiring several experiments at increasing contact
time (CT). This methodology is called Variable Contact Time
(VCT); generally, the CT is increased from few μs to some ms.
A quantitative analysis of the CP data can be performed by
fitting the experimental curves of the CP intensity, I(t), versus
the contact time t. The fitting procedure follows several theoret-
ical models. A complete description of the theory and practical
considerations is reported in the review article of Kolodziejski
and Klinowski [14]. In the following, we will describe in detail
two models: the classical I–S model and the I–I*–S model.
The classical I–S model
This theoretical model, initially developed by Mehring [15], is
based on the classical spin thermodynamics. The system is de-
scribed as consisting of a lattice with a huge heat capacity and
two subsystems, the isolated S spins and an extended network
of coupled I spins. The heat capacity of the rare S spins is much
lower than that of I spins. According to this model, the spins I
are characterized by a rapid spin diffusion so that they behave
as a single spin system at a uniform spin temperature.
After the initial excitation pulse of the I spins, when the Hart-
mann–Hahn condition is met the magnetization is transferred
from the I spins to the observed S spins. The schematic repre-
sentation of the CP process is shown in the left-hand part of
Figure 1.
The enhanced signal of the S spins detected as a function of the
of cross-polarization contact time, t, is expressed as follows
(Equation 1):
(1)
where kIS is the rate constant for the “heat flow” between the I
and S spins, and kI, kS are the inverse of the spin-lattice relaxa-
tion times in the rotating frame for the spin I (T1ρ(H)) and S
(T1ρ(S)), respectively. The simplified Equation (2) is obtained
assuming that: 1) kS < kIS (kS is negligible), 2) kIS + kS > kI, the
system is in the fast CP regime.
(2)
According to Equation 2, the magnetization of the S spins rises
with the CP rate constant kIS, reaches the maximum SCPMAX at
time tMAX and, subsequently, decreases with the time constant
kI. Some experimental curves showing the trends mentioned
before are shown in Figure 7. Finally, the two relaxation param-
eters TCH and T1ρ(H) can be determined, in principle, by fitting
the experimental curves with the bi-exponential Equation 2.
The I–I*–S model
In the I–I*–S model, the reservoir of the I (1H) nuclei surround-
ing a given S (13C) nucleus is divided into two subsets: I* indi-
cates the protons closest to the observed S nucleus, I the nuclei
at longer distances. This model was proposed to explain the
case when the proton spin diffusion rate 1/TDiff is not fast
Beilstein J. Org. Chem. 2017, 13, 182–194.
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enough so that the I spins do not behave as a whole spin system.
The I*–S spin pairs are isolated from the spin network and
exchange polarization in an oscillatory mode. The oscillations
are damped by the spin-diffusion contact with the whole I spin
system. A schematic representation of the physical process is
reported in the right-hand side panel of Figure 1. The oscilla-
tory CP kinetics is described [16] by the Equation 3:
(3)
where b is the heteronuclear dipolar coupling. Further mathe-
matical developments allow determining the composition of the
spin cluster.
The oscillatory behaviour of the signal intensity in 1H–13C VCT
experiments was observed for the first time on single crystals
[16-18]. It was found that the frequency of oscillation depends
on the heteronuclear dipolar coupling b due to the orientation of
the single crystal respect to the external magnetic field. Later
on, similar results have been found for other systems, including
powders, bilayers, and supramolecular complexes [19].
Comparing the two models, it was demonstrated that the I–I*–S
model applies in special cases when the whole spin system has
strong I*–S dipolar interactions and weak homonuclear I-I*
dipolar couplings [14]. In the opposite case, i.e., when weak
I*−S and strong I−I* couplings are present, the CP kinetics
follow the more general I−S model. As a final remark, we wish
to stress that the oscillatory behaviour described above has not
been reported frequently so far, and that the data reported
and discussed in the following of this work represent an exam-
ple.
Results and Discussion
Solid-state NMR
1H MAS NMR spectroscopy
1H high-resolution spectra of small organic molecules, charac-
terised by the isotropic chemical shift and J couplings, are
easily obtained in solution. By contrast, for rigid solids, the cor-
responding solid-state 1H NMR spectrum generally shows
broad, featureless lines due to the strong homonuclear dipolar
couplings among protons, which in many cases exceed the
range of chemical shifts. Consequently, solid-state 1H NMR
spectra are seldom reported, the assignment of the 1H reso-
nances and quantitative analysis of SS 1H NMR spectra is still
very challenging. The spectral resolution can be improved by
applying line narrowing techniques such as magic angle sample
spinning (MAS) [20], usually combined with complex homonu-
clear decoupling pulse sequences designed ad hoc [21,22]. The
resolution of the solid-state NMR signals strongly depends on
the sample spinning speed, for diluted nuclei (13C or 15N) slow
or moderate speeds are enough to obtain resolved spectra, while
fast or very fast spinning (spinning regime >50 kHz) conditions
are needed to obtain “liquid like spectra”.
We begin the spectroscopic investigation of the systems by
discussing the proton MAS spectra of the two nanosponges
CDNS(1:8) and CDNS(1:4) free and IbuNa loaded according to
the procedure described in the experimental section. The
1H MAS NMR spectra of both nanosponges CDNS(1:8) and
CDNS(1:4) (Figure 2b), acquired at 20 kHz spinning speed, ex-
hibit broad lines characteristic of a rigid solid due to a not com-
plete averaging of the strong homonuclear 1H–1H dipolar inter-
actions. A different NMR pattern is observed for the CDNS-
drug samples. The 1H spectrum of the sample CDNS(1:8)-
IbuNa (Figure 2a) shows narrow resolved signals of the drug
molecule and a broad line for the polymeric network. Similarly,
the 1H MAS spectrum (Figure 2b) of CDNS(1:4)-IbuNa shows
resolved peaks (line widths of 40–50 Hz) of the drug molecule.
Figure 2: 1H MAS NMR spectra of a) CDNS(1:8)-IbuNa and
b) CDNS(1:8). The inset (top right) shows the expansion of the spec-
tral region where the hydrogen bonded protons of the carboxylic func-
tional groups resonate. The notation CDNS-IbuNa indicates the orig-
inal preparation, irrespective of the conversion of the sodium salt into
the undissociated acid.
Signal resolution further increases under fast MAS (40 kHz
spinning) conditions (Figure 3c). The observed high resolution
of the IbuNa spectral lines is the consequence of the efficient
averaging of the homonuclear 1H–1H dipolar interactions due to
fast rotation of the sample at the magic angle. All the reso-
nances can be easily assigned. The peak at 0.96 ppm is due to
the methyl groups, small peaks belonging to the alkyl protons
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 3: The effect of the spinning speed on the spectral features. 1H MAS NMR spectra of a) CDNS(1:4)-IbuNa under conditions of fast spinning
speed (40 kHz), b) CDNS(1:4)-IbuNa recorded at lower spinning speed (20 kHz), c) CDNS(1:8)-IbuNa recorded at 20 kHz spinning speed. The nota-
tion CDNS-IbuNa indicates the original preparation, irrespective of the conversion of the sodium salt into the undissociated acid. The arrow indicates
the peak assigned to the hydrogen bonded dimer, sketched in the inset.
are in the range 1.4–3.6 and the resonances at 7–7.23 are due to
the phenyl group. It is important to observe a high frequency
signal at 12.05 ppm for CDNS(1:8) and at 13 ppm for
CDNS(1:4). This peak is indeed unexpected, as it is assignable
to carboxylic protons involved in hydrogen bonds. The pres-
ence of such a signal provides evidence for two remarkable
facts: i) the drug entrapped in the nanosponge is in the acidic
form, and ii) the ibuprofen molecules hosted in the CDNS are
fully involved in a hydrogen-bond network. This point is worth
of a comment: racemic IbuH was reported [23] to form dimers
in the crystal state, as assessed by the combined single crystal
X-ray and pulsed neutron diffraction techniques. In the present
study, the observed 1H NMR peak assignable to a hydrogen
bonded proton seems to indicate a similar situation, i.e., dimeric
IbuH confined in CDNS linked by IbuH∙∙∙IbuH interactions.
However, it should be kept in mind that other types of hydro-
gen bonds may be established, such as those between IbuH and
the free OH groups of CD or the COOH and amino functional
groups of the cross-linker. The acidic IbuH form present in the
network can be motivated by considering that, even if the
swelling of CDNS is achieved by adding an aqueous basic solu-
tion of sodium carbonate [9], the final pH of the hydrogel is
slightly acidic. Moreover, water removal by lyophilisation in-
duces an increased protonation of IbuH, due to the concentra-
tion of the system.
13C CP-MAS NMR spectroscopy
In order to get more information on the CDNS polymer
structure, polymer–drug interactions and drug mobility, we re-
corded the 13C CP-MAS spectra for several samples of free
CDNS and the corresponding drug-loaded samples. Three dif-
ferent types of samples were studied: 1) free polymers
CDNS(1:4) and CDNS(1:8); 2) pure IbuNa; 3) CDNS(1:4)-
IbuNa and CDNS(1:8)-IbuNa.
Both spectra of the CDNS polymers, reported in Figure 4, show
broad lines characteristic of amorphous materials. The top trace
of Figure 4 shows the characteristic spectrum of crystalline
β-CD, along with the peak assignment already known from the
literature. The peak assignment is a guide for the interpretation
of the spectra of CDNS. The observed chemical shifts follow
the order C(1), C(4), [C(5), C(3) and C(2)] and C(6), in increas-
ing order of shielding. For both CDNS polymers, the peak as-
signment is reported in Table 1.
The 13C CP-MAS spectrum of IbuNa is reported in Figure 5
(top trace). It was acquired as reference spectrum of the drug
molecule and the resonances assigned according to Geppi et al.
[24]. The spectrum shows sharp lines (line-width range:
80–100 Hz) specific of a crystalline sample. Ibuprofen is a
small molecule characterized by an interesting internal dynamic
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 4: 13C CP-MAS NMR spectra for samples of β-CD (top), CDNS(1:4) (middle) and CDNS(1:8) polymers (bottom). CL indicates the carbonyl
group of the cross-linking agent.
Table 1: Chemical shift (ppm), and proton relaxation T1ρ (ms) of the carbon atoms of CDNS(1:4), CDNS(1:8) polymers and pristine β-CD.
Carbon atoms Chemical shifta T1ρ CDNS(1:4)a T1ρ CDNS(1:8)a T1ρ β-CDb
CL (carbonyl) 170 3.3 3.0
C(1) 102 3.3 5.0 2.6
C(4) 82 3.3 5.0 2.4–2.6
C(2), C(3), C(5) 72 3.3 5.0 2.2–2.5
C(6) + CL (methylene) 56 3.0 5.0 2.7
aThis work. bFrom ref. [26].
behaviour due to two main molecular fragments: the alkyl chain
and the aromatic ring. The internal motion was studied in detail
using solid-state 13C NMR spectroscopy at different tempera-
tures by Carignani et al. [25]. The authors identified two types
of motion with a different time scale: 1) the rotations of the two
methyl groups of the isobutyl moiety, occurring in the fast
regime, 2) the π-flip of the phenyl ring belonging to the inter-
mediate motional regime.
Both rotational motions are fast enough to observe an average
isochronous signal for the methyl carbon atoms (12 and 13) as
well as for the aromatic protonated carbons (5,6–7,8). It is
worth reminding that a different mobility was observed for
ibuprofen in its acid form (IbuH) which shows hindered rota-
tional motion for both molecular fragments.
The 13C CP-MAS NMR spectra of the CDNS samples without
and with ibuprofen are also shown in Figure 5. A comparison of
the reported spectra does not highlight any observable change
of the linewidth and chemical shift of the CDNS signals after
loading the polymers with IbuNa. This is a clear indication that
adding the drug to the CDNS does not influence significantly
the nanosponge porous structure. From the point of view of the
encapsulated drug, the 13C CP-MAS spectra show that the
peaks due to ibuprofen retain high resolution even when the
drug is encapsulated in the nanosponges, thus proving that the
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 5: 13C CP-MAS NMR spectrum of: a) CDNS(1:4) polymer; b) CDNS(1:4)-IbuNa system; c) CDNS(1:8)-IbuNa system; d) pure IbuNa (refer-
ence spectrum). The molecular structure and atom numbering of IbuNa are shown in the inset. The notation CDNS-IbuNa indicates the original prepa-
ration, irrespective of the conversion of the sodium salt into the undissociated acid.
drug is in a crystalline form inside the rigid polymeric network.
However, two important findings should be highlighted here.
The peaks assigned to C12 and C13 of IbuNa – which are
isochronous in the reference sample (Figure 5d) and they give
rise to a singlet at ca. 23 ppm – provide two separate signals
when IbuNa is loaded onto the polymers, as clearly visible in
Figure 5b and c. This finding further supports what described in
the previous section: the guest molecule ibuprofen, originally
added to the polymeric matrix as the sodium salt IbuNa, is
present, in the CDNS(1:4) and CDNS(1:8) nanosponges, as the
corresponding acid form IbuH. Indeed, the chemical shift of
ibuprofen signals from the spectra of Figure 5b and 5c match
with those reported in the literature for the 13C CP-MAS NMR
spectrum of crystalline IbuH [25]. The indication that IbuH is
not significantly interacting with the polymeric backbone and
that the 13C CP-MAS NMR chemical shift of encapsulated
IbuH match those of pure, crystalline IbuH provide useful, addi-
tional information to spot on the nature of the hydrogen bond
network introduced in the previous section. As significant
IbuH···CDNS interactions are not detected, the hydrogen bond
detected via 1H NMR and discussed in the previous section is
likely to involve two IbuH units in the formation of dimers.
Dynamics of cross polarization
We applied variable contact time (VCT) 1H-13C CP-MAS
NMR techniques to study the CP kinetics of both the CDNS
polymers. As an example, the array of 13C CP-MAS spectra
acquired at the MAS rate of 10 kHz and with increasing contact
time for cross-polarization is shown in Figure 6 in the case of
CDNS(1:4). We can observe that at 100 μs all the carbon atoms
are polarized, i.e., the signal intensity is high enough to generate
an observable 13C CP-MAS NMR spectrum. The maximum
signal intensity SCPMAX is observed around 750 μs for all the
cyclodextrin carbon atoms and around 1100 μs for the carbonyl
groups of the cross-linker. Such small values indicate a fast
cross-polarization process, consistent with a rigid polymeric
system. Therefore, strong heteronuclear dipolar interactions are
present and capable to facilitate an effective magnetization
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 6: 13C CP-MAS NMR spectra of CDNS(1:4) acquired with CP variable contact time in the range 50 μs–7 ms.
Figure 7: Time dependence of 13C magnetization for CDNS(1:4) (left) and CDNS(1:8) (right) polymers.
transfer from the proton reservoir to various carbon atoms. The
CP kinetics in both CDNS systems follow the classical I–S
model. The signal intensity I(t), expressed by the peak area,
versus the CP contact time t are reported in Figure 7 for all the
carbon atoms.
The experimental curves can be fitted by using Equation 2, thus
providing the values of the proton relaxation parameter T1ρ. The
results are collected in Table 1 for CDNS(1:4), CDNS(1:8). For
clarity, also the literature T1ρ values related to monomeric
β-cyclodextrin are listed [26]. All the carbon atoms revealed
Beilstein J. Org. Chem. 2017, 13, 182–194.
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Figure 8: 1H-13C CP oscillatory kinetics for the carbon C(1) and C(4) of CDNS(1:4)-IbuNa sample (left) and CDNS(1:8)-IbuNa (right). The notation
CDNS-IbuNa indicates the original preparation, irrespective of the conversion of the sodium salt into the undissociated acid.
short T1ρ values in the range of 3–5 ms and similar for β-CD
C atoms and the carbonyl atom of the cross-linker, suggesting
that their chemical environments are equally proximate to the
1H reservoirs. This result is indicative of the homogeneous
nature of the polymer sample. The only exception to this
general trend is observed for the cross-linker C atom of
CDNS(1:8). In such a case, T1ρ of 3 ms was detected, while all
the other C atoms show the constant value of 5 ms. This finding
confirms a certain degree of heterogeneity in CDNS(1:8)
connected to the carbonyl groups of the CL in this polymer, in
agreement with the observation previously reported for the
same system in the gel state [9].
A different, more complex, kinetic behaviour is obtained for
both the CDNS-IbuNa samples. For all the carbon atoms of the
CDNS polymer as well as for all the carbons of ibuprofen, our
VCT results followed a non-classical kinetic model (I–I*–S
model) corresponding to oscillatory polarization transfer. The
results for the C(1), C(4) atoms of the CDNS(1:4) and
CDNS(1:8) polymers are shown in Figure 8 and Figure 9, re-
spectively. The dipolar oscillations modulate the magnetization
build-up curve at short mixing times up to 750 μs, then the time
constants (proton spin diffusion Tdiff and proton spin–lattice re-
laxation in the rotating frame T1ρ) determine the magnetization
decay.
The CP kinetic curve of ibuprofen (aromatic carbons 6, 8) is
shown in Figure 9. In this case, the magnetization intensity rises
at short mixing times (in the range 50–1100 μs) and then ap-
proaches a plateau which means that T1ρ (H) is infinitely long.
Figure 9: 1H-13C CP oscillatory kinetics for the ibuprofen aromatic
carbon atoms C(6,8) in samples CDNS(1:4)-IbuNa and CDNS(1:8)-
IbuNa. The notation CDNS-IbuNa indicates the original preparation,
irrespective of the conversion of the sodium salt into the undissociated
acid.
The process of drug loading in both CDNS polymers influences
the dynamic behaviour of both the polymer and the drug due to
strong heteronuclear dipolar interactions rising in a rigidly
connected system. A more detailed analysis of these systems
would need a deeper theoretical data treatment. Additionally, in
order to achieve an accurate fitting, some relaxation parameters
Beilstein J. Org. Chem. 2017, 13, 182–194.
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need to be determined with different solid state experiments
such as depolarization or the TORQUE [27] experimental
method, which is beyond the aim of this work. In the economy
of the present work, the most important conclusion of this
section is that the VCT profiles of the free polymers –
CDNS(1:4) and CDNS(1:8) – and the corresponding drug-
loaded formulations – CDNS(1:4)-IbuNa and CDNS(1:8)-
IbuNa – fit two different dynamic models: the commonly ob-
served I–S scheme and the non-classic, less common I–I*–S
model, respectively. The changes observed in the dynamics of
the system after the drug loading point out that the polymer and
the drug are in contact (dipolar contact) and that the magnetiza-
tion is transferred from the protons (of both polymer and drug)
to the CDNS carbons. This allows to conclude that a supramo-
lecular architecture is formed, in spite of the fact that the initial
structure of the CDNS polymer is retained.
Powder X-ray diffraction
The diffraction patterns of both CDNS used in the present work
(Figure 10a and b) show a totally amorphous structure in agree-
ment with the results of 13C CP-MAS NMR. Once loaded with
ibuprofen sodium salt, the PXRD profiles of both CDNS
(Figure 10c and d) show the amorphous structure of CDNS
along with peaks belonging to ibuprofen. The ibuprofen Bragg
peaks are intense and sharp, typical for a high ordered crys-
talline structure. Their positions are in agreement with the
diffraction pattern of the acidic racemic form of ibuprofen, thus
confirming that, after the lyophilisation, the IbuNa originally
added to the nanosponge is turned into the undissociated acid
IbuH. For comparison, the spectrum of a standard sample of
pure, racemic ibuprofen in its acidic form (IbuH) is also re-
ported in the figure (Figure 10e). The peak positions match
perfectly the literature reference [28] and they are clearly distin-
guishable from the reflexes of IbuNa, shown in upper traces of
the figure (Figure 10f).
As a final remark, the PXRD patterns show that ibuprofen
entrapped into the nanosponge network still retains crystallinity,
thus confirming that the formation of the polymer-drug associa-
tion is a mild process.
Conclusion
The mesoporous materials CDNS(1:4), CDNS(1:8) in their free
form and loaded with ibuprofen sodium salt were prepared and
thoroughly characterized using solid-state 1H Fast MAS and
13C CP-MAS NMR spectroscopy. The main conclusions can be
summarized as follows:
1. Ibuprofen sodium salt is converted into its acid form IbuH
after the lyophilisation of the hydrogels obtained by swelling
CDNS(1:4) and CDNS(1:8) with aqueous IbuNa solutions.
Figure 10: PXRD patterns of: a) CDNS(1:8), b) CDNS(1:4),
c) CDNS(1:8)-IbuNa loaded, d) CDNS(1:4)-IbuNa loaded, e) IbuH, an-
alytical standard, f) IbuNa, analytical standard, The notation CDNS-
IbuNa indicates the original preparation, irrespective of the conversion
of the sodium salt into the undissociated acid.
2. 1H Fast MAS NMR spectra reveal that ibuprofen loaded in
the CDNS polymeric scaffold does not form H-bonds with the
polymer, but rather it crystallizes as a dimer.
3. 13C CP-MAS spectra allow the characterization of the free
CDNS polymers as amorphous materials. 13C CP-VCT experi-
ments show that the investigated cyclodextrin nanosponges are
rigid and homogeneous.
4. 13C CP-MAS spectra of the CDNS and the CDNS-drug
systems do not show observable chemical shift changes, thus
ruling out significant structural changes (e.g., conformational or
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structural) for the polymer backbone after the entrapment of the
drug.
5. Conversely, 13C CP-VCT NMR experiments provide evi-
dence that the kinetic behaviour of all the carbon atoms of the
CDNS polymers dramatically changes upon drug loading, thus
providing a dynamic fingerprint of the formation of a supramo-
lecular architecture. The latter is characterized by the formation
of IbuH domanins in the pores of the 3D structure of the poly-
meric network. The experimental data show that the inclusion
of IbuH in the CD cavity – namely the formation of a
host–guest inclusion complex – does not occur, confirming the
situation already described by HR-MAS NMR data for the same
system in the gel state [9] and outlining a different scenario on
passing from monomeric CD, capable to form well character-
ized inclusion complexes with IbuH [29-31] to CDNS of the
present work. A possible explanation relies upon the availabili-
ty of the CD cavity within the polymeric network. The impor-
tance of this factor is particularly clear in the case of polymers
obtained by monomers containing cyclodextrin units as
dangling groups, e.g., glycidylmethacrylate-mono-6-amino-6-
deoxy-β-CD (GMA-NH2-β-CD) co-polymerized with ethylene
dimethacrylate [32]. The corresponding cross-linked polymers
are thus decorated with cyclodextrin units, easily accessible to
small molecules to give rise to inclusion complexes. This type
of polymers showed excellent efficiency as chiral selectors for
the enantioseparation of racemic ibuprofen [32]. In our case, the
primary OH groups of CD units react with EDTA dianhydride
to form a cross-linked polyester. As a matter of fact, this type of
polycondensation makes the CD cavity less available compared
to the former case. The overall result is that the guest mole-
cules are mainly confined in the pores formed by the polycon-
densation process rather than forming a genuine inclusion com-
plex with the single CD units. From a practical point of view,
our class of polymerized cyclodextrins can be conveniently
exploited as sorbent or scaffold by exploiting the pores of the
polymer network to encapsulate the guest molecules. However,
it should be stressed that CD nanosponges similar to ours and
prepared by using citric acid as cross-linker, showed a different
behaviour towards ibuprofen: the authors provided evidence of
inclusion complex formation as the main mechanism of absorp-
tion [33]. We may conclude that the type of monomer and the
cross-linker agent both play a key role in driving the absorption
towards inclusion complexes or segregation in the polymer
pores, although a sufficient number of data is still missing to
formulate a general model.
As a final remark, the possibility of solid-state reactions involv-
ing the active components should be taken into account when
designing scaffolds for in situ release. The methodologies here
described can be conveniently included in the tool-case to
monitor the molecular state and dynamics of the host–guest
systems.
Experimental
Materials and measurements
The detailed procedures for the synthesis of CDNS and the
preparation of the corresponding hydrogels containing IbuNa
can be found and seen in [34]. In the following, we report the
essential information on the synthesis and the experimental
details for the NMR and XRD experiments.
Nanosponges preparation and drug loading proce-
dure
The synthesis of CDNS(1:4) and CDNS(1:8) was done accord-
ing to the protocol previously described [9]. The drug loading
procedure consists of three fundamental steps:
1. A stock solution (0.27 M) of ibuprofen sodium salt was
prepared by dissolving 308 mg of IbuNa together with
68 mg of Na2CO3 in 5 mL of water.
2. 3 mL of the solution (1) were then added to a weighted
amount (400 mg) of CDNS polymer in both prepara-
tions.
3. Homogeneous hydrogels were then obtained in 1 h. The
measured pH of the gels was 6.5. The samples are then
freeze-dried overnight.
Solid state NMR spectroscopy
1H NMR spectra were recorded on VNMRS spectrometer oper-
ating at 600 MHz (51 mm bore Oxford superconducting
magnet) equipped with a 1.6 mm Triple Resonance Fast MAS
probehead. Sample rotation frequencies were 20–40 kHz for
1H Fast MAS NMR experiment.
13C CP-MAS NMR spectra were collected at 125.77 MHz on
the 500 MHz NMR Spectrometer AvanceTM 500 operating at a
static field of 11.7 Tesla (superconducting ultrashield magnet)
and equipped with a 4 mm MAS probe. All the samples were
prepared by packing the powder in Zirconia rotors (ZrO2),
closed with Kel-F caps (80 μL internal volume); the spinning
speed (MAS) was optimized at 10 kHz.
Cross-polarization (CP) spectra, under Hartmann–Hahn condi-
tions, were recorded with a variable spin-lock sequence (ramp
CP-MAS), a relaxation delay d1 = 4 s, and a 1H π/2 pulse-width
of 4.2 μs was employed. The contact time (CT) for the VCT ex-
periments was varied in the range of 50 μs to 7.0 ms;
1200 scans for each experiment were acquired.
The CP-MAS signals were approximated by Lorentzian func-
tion curve fitting analysis. The baseline and the deconvolution
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of the peaks were performed with OriginPro 2016 software. The
accordance between experimental and deconvoluted curves is
expressed as R2 value which is >0.98 for all of the analyzed
spectra.
X-ray diffraction experiments
The powder X-ray diffraction (PXRD) experiments were per-
formed with a Bruker D2 Phaser X-ray powder diffractometer
using CuKα radiation. The data were collected in the 2θ range
2.3–40° with a step size of 0.02° and a counting time of 0.4 s
per step, a primary slit module of 0.6 mm, air scatter screen
module 1 mm and secondary slit module 8 mm.
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